RRM2 and frontotemporal dementia: RRM2 (ribonucleotide reductase regulatory subunit M2), a downstream target of HNRNPK involved in DNA damage response, exhibits increased nuclear translocation but decreased expression in C9orf72 ALS/FTD patient tissue.